Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 1,548 shares at $27.66 ($43K) on 2023-02-09, disclosed to the SEC on 2023-02-13.
Scheduled sale ($43k) by EVP, Head of International under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2025-04-10 | $2.2M | — | Filing → |
| RYTM | SELL | 2025-03-18 | $7.7M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |